Retail Traders Pivot to Merck, Bail on Vaccine Stocks After Data

This post was originally published on this site

[unable to retrieve full-text content]The day-trading crowd is embracing drug heavyweight Merck & Co.’s oral antiviral treatment, and moving on from Covid vaccine stocks, as investors weigh the outlook for treatments to combat and prevent …